Oropharyngeal Squamous Cell Carcinoma

Primary transoral robotic surgery appeared associated with greater risk for short-term dysphagia compared with primary radiotherapy or chemoradiotherapy among patients with T1-T2 oropharyngeal squamous cell carcinoma, study results showed.

De-escalated intensity-modulated radiotherapy plus concurrent cisplatin satisfied criteria for further study among patients with HPV-related oropharyngeal squamous cell carcinoma, according to phase 2 study results.